P930038/S107: Angio Seal VIP Vascular Closure Device
FDA’s recorded scope: the addition of a new U.S. farm and a new USDA-registered abattoir for collagen
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 7 FDA records to the applicant name Terumo Medical Corporation. 3 entries are PMA supplements. 4 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Aug 5, 2025 to Aug 4, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code NIP appears in 4 of the 7 linked filings. The collection spans 3 FDA product codes and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P140002, with 5 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 950 Elkton Blvd., Elkton, MD, 21921. Recorded on P930038/S107, decision dated Aug 4, 2026.
Device, Hemostasis, Vascular; Stent, Iliac; Stent, Superficial Femoral Artery.
FDA’s recorded scope: the addition of a new U.S. farm and a new USDA-registered abattoir for collagen
FDA’s recorded scope: The Misago RX Self-expanding Peripheral Stent is indicated to improve the luminal diameter in patient with de novo, restenotic and/or occlusive atherosclerotic lesion(s) in the common and/or external iliac artery. The reference vessel diameters range from 4.0 mm to 9.0 mm and the lesion length is up to 120 mm.
FDA’s recorded scope: approval for an additional silicone oil manufacturer
FDA’s recorded scope: packaging material, performance testing, and label placement changes
FDA’s recorded scope: changes to the endotoxin test procedures and the addition of a lubricant to non-patient-contacting components
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Terumo Medical Corporation | Class II | Aug 19, 2026 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 21, 2026.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Angio Seal VIP Vascular Closure DeviceP930038/S107 | Terumo Medical Corporation | PMA supplement | Aug 4, 2026 | FDA |
MISAGO(TM) RX Self-expanding Peripheral StentP140002/S032 | Terumo Medical Corporation | PMA supplement | Jul 16, 2026 | FDA |
MISAGO RX Self-expanding Peripheral StentP140002/S033 | Terumo Medical Corporation | PMA supplement | Feb 13, 2026 | FDA |
MISAGO RX Self-expanding Peripheral StentP140002/S031 | Terumo Medical Corporation | PMA supplement | Dec 12, 2025 | FDA |
MISAGO RX Self-expanding Peripheral StentP140002/S030 | Terumo Medical Corporation | PMA supplement | Sep 12, 2025 | FDA |
Angio-Seal Vascular Closure DeviceP930038/S106 | Terumo Medical Corporation | PMA supplement | Aug 7, 2025 | FDA |
| Terumo Medical Corporation | PMA supplement | Aug 5, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.